Gene · 776
Papers2,356
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,356
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evolutionary Characteristics in Primary Aldosteronism Patients. | Hypertension | 2025 | 39502033 | PubTator, text mining | PubMed |
| CaMKIIα-TARPγ8 signaling mediates hippocampal synaptic impairment in aging. | Aging Cell | 2025 | 39380368 | PubTator, text mining | PubMed |
| Inactivation induced by pathogenic Cav1.3 L-type Ca2+-channel variants enhances sensitivity for dihydropyridine Ca2+ channel blockers. | Br J Pharmacol | 2025 | 39370994 | PubTator, text mining | PubMed |
| Emerging Role of CircularRNA-Cacna1d in Sepsis-induced Lung Injury: A Potential Therapeutic Target and Biomarker. | Am J Respir Cell Mol Biol | 2025 | 39288398 | PubTator, text mining | PubMed |
| Circular RNA-Cacna1d Plays a Critical Role in Sepsis-induced Lung Injury by Sponging microRNA-185-5p. | Am J Respir Cell Mol Biol | 2025 | 39236286 | PubTator, text mining | PubMed |
| A biallelic mutation in CACNA2D2 associated with developmental and epileptic encephalopathy affects calcium channel-dependent as well as synaptic functions of α2δ-2. | J Neurochem | 2025 | 39161180 | PubTator, text mining | PubMed |
| Sclareol exerts an anti-inflammatory effect, possibly through COXs inhibition pathway: In vivo and in silico studies. | Pharm Sci Adv | 2024 | 41550165 | PubTator, text mining | PubMed |
| Autism-Linked Mutations in α2δ-1 and α2δ-3 Reduce Protein Membrane Expression but Affect Neither Calcium Channels nor Trans-Synaptic Signaling. | Pharmaceuticals (Basel) | 2024 | 39770450 | PubTator, text mining | PubMed |
| CaBP1 and 2 enable sustained CaV1.3 calcium currents and synaptic transmission in inner hair cells. | Elife | 2024 | 39718549 | PubTator, text mining | PubMed |
| Immune-related diagnostic markers for benign prostatic hyperplasia and their potential as drug targets. | Front Immunol | 2024 | 39703506 | PubTator, text mining | PubMed |
| Is Cav1.3 a feasible therapeutic target for a rare neurodevelopmental disorder? | Expert Opin Ther Targets | 2024 | 39670814 | PubTator, text mining | PubMed |
| Adiponectin receptor 1-mediated basolateral amygdala-prelimbic cortex circuit regulates methamphetamine-associated memory. | Cell Rep | 2024 | 39661515 | PubTator, text mining | PubMed |
| Genetic Variations in Hyperinsulinemic Hypoglycemia: Active versus Inactive Mutations. | Diabetes Metab Syndr Obes | 2024 | 39619217 | PubTator, text mining | PubMed |
| Ion channels research in hPSC-RPE cells: bridging benchwork to clinical applications. | J Transl Med | 2024 | 39604931 | PubTator, text mining | PubMed |
| Generation of an iPSC cell line (VANYHHi001-A) from a patient with cardiac arrythmias carrying CACNA1D, SCN5A, and DSP variants. | Stem Cell Res | 2024 | 39551029 | PubTator, text mining | PubMed |
| Opto-chemogenetic inhibition of L-type CaV1 channels in neurons through a membrane-assisted molecular linkage. | Cell Rep Methods | 2024 | 39515337 | PubTator, text mining | PubMed |
| Pharmacogenomic Study of Selected Genes Affecting Amlodipine Blood Pressure Response in Patients with Hypertension. | Pharmgenomics Pers Med | 2024 | 39492848 | PubTator, text mining | PubMed |
| Protein structural context of cancer mutations reveals molecular mechanisms and candidate driver genes. | Cell Rep | 2024 | 39441719 | PubTator, text mining | PubMed |
| Somatic GNAQ, CTNNB1, and CACNA1C Mutations in Cat Aldosterone-Secreting Tumors. | Hypertension | 2024 | 39429164 | PubTator, text mining | PubMed |
| Supercomputer framework for reverse engineering firing patterns of neuron populations to identify their synaptic inputs. | Elife | 2024 | 39412386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/776/papers?page=6